Faropenem
- Generic Name
- Faropenem
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H15NO5S
- CAS Number
- 106560-14-9
- Unique Ingredient Identifier
- F52Y83BGH3
- Background
Faropenem has been used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and Community Acquired Pneumonia.
- Indication
用于皮肤及软组织、呼吸系统、泌尿生殖系统及眼、耳、鼻、喉口腔等部位的敏感菌感染。
- Associated Conditions
- -
- Associated Therapies
- -
Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers
- Conditions
- Tuberculosis
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 43
- Registration Number
- NCT02393586
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers
- Conditions
- Pulmonary Tuberculosis
- Interventions
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 58
- Registration Number
- NCT02381470
- Locations
- 🇵🇭
Tropical Disease Foundation, Makati City, Philippines
🇵🇭De La Salle Health Institute, Cavite, Philippines
🇸🇬National University Hospital, Singapore, Singapore, Singapore
Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis
- Conditions
- Pulmonary Tuberculosis
- Interventions
- First Posted Date
- 2015-01-29
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- TASK Applied Science
- Target Recruit Count
- 46
- Registration Number
- NCT02349841
- Locations
- 🇿🇦
TASK Foundation NPC, Cape Town, Western Cape, South Africa
A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
- First Posted Date
- 2013-09-10
- Last Posted Date
- 2013-09-10
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT01937832
- Locations
- 🇨🇳
The Second Hospital of Jilin University, Changchun, Jilin, China
🇨🇳The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Anhui Provincial Hospital, Hefei, Anhui, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.